The global market for population health management is on course to nearly reach the $100 billion threshold within the decade, according to a new report from MarketsandMarkets. The research firm projects the sector will expand from an estimated $27.57 billion in 2024 to $98.41 billion by 2031, representing a compound annual growth rate of 24.1 percent over the forecast period. The scale of that trajectory places population health management among the fastest-growing segments in the broader digital health economy, drawing intensified interest from technology vendors, hospital systems, and institutional investors alike. For context on how macroeconomic conditions are shaping healthcare investment decisions, earlier analysis on Federal Reserve policy remains relevant to understanding the financing environment for capital-intensive health technology deployments.

The report, titled “Population Health Management Market worth $98.41 billion by 2031 — Exclusive Report by MarketsandMarkets,” was distributed via PR Newswire and draws on extensive primary and secondary research across healthcare providers, payers, and technology suppliers. According to MarketsandMarkets research, the surge is being driven by accelerating adoption of value-based care models, growing chronic disease burdens, and the rapid integration of artificial intelligence into clinical analytics platforms.

Value-Based Care and AI Integration Fuel Demand

At the core of the market’s expansion is a structural shift in how healthcare systems are reimbursed. Governments and private insurers across North America and Europe have steadily redirected payment models away from fee-for-service arrangements toward outcomes-based frameworks that reward providers for keeping populations healthier at lower cost. Population health management platforms — which aggregate patient data, flag high-risk individuals, and coordinate care interventions — are central infrastructure for operating under those incentive structures. The commercial logic is straightforward: health systems that fail to invest in these tools risk financial penalties under value-based contracts while those that do can capture shared savings payments that materially improve margins.

Artificial intelligence is amplifying that dynamic. Machine learning models embedded within population health platforms can now identify patients likely to require expensive hospitalizations weeks or months in advance, enabling earlier and less costly interventions. Natural language processing is being deployed to extract clinically meaningful signals from unstructured physician notes, expanding the data inputs available to risk stratification algorithms. Vendors including major enterprise software companies and specialist health IT firms are competing aggressively on the sophistication of these capabilities, compressing product development cycles and accelerating feature rollouts. This pattern of software-led disruption in a heavily regulated sector carries echoes of dynamics seen in other technology markets, including the AI chip space covered in Fiscalist’s earlier reporting on the Hailo acquisition.

Regional and Segment Breakdown Points to North American Dominance

North America is expected to retain the largest share of the global population health management market through 2031, underpinned by the United States healthcare system’s advanced payer infrastructure, its high penetration of electronic health records, and the scale of Medicaid and Medicare value-based care programs administered at the federal level. The region’s established base of integrated delivery networks and accountable care organizations provides a ready customer pool for platform vendors seeking enterprise-scale contracts. Europe is forecast to represent the second-largest regional market, driven by national health service digitization programs in the United Kingdom, Germany, and the Nordic countries.

Within the market’s component structure, software solutions are projected to account for the dominant revenue share, with services — including implementation, consulting, and managed care coordination — contributing a meaningful secondary layer. Cloud-based deployment models are gaining ground over on-premise alternatives as provider organizations seek to reduce capital expenditure and improve interoperability across care settings. The chronic disease management application segment, covering conditions such as diabetes, cardiovascular disease, and chronic obstructive pulmonary disease, is identified as one of the highest-growth use cases given the epidemiological pressures these conditions place on health system capacity globally. With populations aging across most high-income markets and lifestyle-related illness rates continuing to rise, the structural demand underpinning this market appears durable well beyond the immediate forecast window.